Molecular Imaging in Gastric Cancer: [ 18 F]FDG and Fibroblast Activation Protein-Targeted PET/CT
Journal of Gastric Cancer · 2026
DOI: 10.5230/jgc.2026.26.e4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gastric Cancer, 2026. Verfasst von Chaninart Sakulpisuti und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Stomach Neoplasms, Fluorodeoxyglucose F18, Positron Emission Tomography Computed Tomography, Molecular Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korea Health Industry Development Institute.
Abstract (Originalsprache)
Gastric cancer remains a major global health burden, and accurate staging and response assessment are essential for optimal management. 2-[¹⁸F]-Fluoro-2-deoxy-D-glucose ([¹⁸F]FDG) positron emission tomography (PET)/computed tomography (CT) is widely used in oncology. However, it exhibits variable sensitivity in gastric cancer, particularly in poorly cohesive, mucinous, and signet ring cell carcinomas with low glucose metabolism. These limitations have prompted interest in fibroblast activation protein-targeted imaging, which visualizes the tumor stroma rather than the tumor cells. Radiolabeled fibroblast activation protein inhibitors (FAPIs) exhibit high tumor-to-background contrast and consistent uptake across histological subtypes, offering improved lesion detectability even in [¹⁸F]FDG-negative tumors. This review outlines the evolving role of PET/CT in gastric cancer, with a focus on [¹⁸F]FDG and FAPI tracers. Comparative evidence indicates that FAPI PET/CT enhances diagnostic accuracy, provides complementary information for evaluating treatment response, and offers potential theranostic applications. Further prospective studies are needed to establish standardized protocols and define the clinical impact of FAPI PET/CT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Division of Nuclear Medicine, Department of Diagnostic and Therapeutic Radiology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
- Department of Nuclear Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. mandu3710@gmail.com.
ORCID-Profile: Chaninart Sakulpisuti, Minseok Suh
Förderung
- Korea Health Industry Development Institute
Zitieren
APA
Sakulpisuti, C., & Suh, M. (2026). Molecular Imaging in Gastric Cancer: [ 18 F]FDG and Fibroblast Activation Protein-Targeted PET/CT. Journal of Gastric Cancer. https://doi.org/10.5230/jgc.2026.26.e4
Vancouver
Sakulpisuti C, Suh M. Molecular Imaging in Gastric Cancer: [ 18 F]FDG and Fibroblast Activation Protein-Targeted PET/CT. Journal of Gastric Cancer. 2026. doi:10.5230/jgc.2026.26.e4
BibTeX
@article{Sakulpisuti2026,
author = {Sakulpisuti, Chaninart and Suh, Minseok},
title = {Molecular Imaging in Gastric Cancer: [ 18 F]FDG and Fibroblast Activation Protein-Targeted PET/CT},
journal = {Journal of Gastric Cancer},
year = {2026},
doi = {10.5230/jgc.2026.26.e4}
}
EUVIMED